Literature DB >> 12906346

Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report.

Larissa Elgudin1, Yvonne Hall, Daniel Schubert.   

Abstract

Valproic acid is widely used as a mood stabilizer. We report a case of an adult with bipolar disorder taking therapeutic doses of valproic acid, who presented to the emergency department with coma related to hyperammonemia as a complication of valproic acid treatment. Valproic acid was discontinued which resulted in rapid clinical recovery. Valproic acid induced coma was likely related to a urea cycle enzymopathy. Clinicians should consider hyperammonemia in all patients who present with coma and other mental status changes while on valproic acid. In such patients, ammonia level should be obtained in addition to liver function tests.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12906346     DOI: 10.2190/XW8E-Q283-4429-QL71

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  4 in total

Review 1.  Valproate-induced hyperammonaemia superimposed upon severe neuropsychiatric lupus: a case report and review of the literature.

Authors:  Estee Chan; Fiona McQueen
Journal:  Clin Rheumatol       Date:  2012-12-28       Impact factor: 2.980

Review 2.  Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy.

Authors:  Saul W Brusilow; Raymond C Koehler; Richard J Traystman; Arthur J L Cooper
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

Review 3.  Fifteen years of urea cycle disorders brain research: Looking back, looking forward.

Authors:  Kuntal Sen; Matthew Whitehead; Carlos Castillo Pinto; Ljubica Caldovic; Andrea Gropman
Journal:  Anal Biochem       Date:  2021-10-09       Impact factor: 3.365

4.  A Case of Valproic-Acid Induced Hyperammonemic Encephalopathy.

Authors:  Kinza Iqbal; Hardhik Kummamuru; Naresh Dasari; Thoyaja Koritala; Nitesh K Jain; Keerti Deepika; Ramesh Adhikari
Journal:  Cureus       Date:  2021-12-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.